News
Featured news
Latest news
Tirzepatide, a drug to treat obesity
A weekly dose for a year and a half has been shown to reduce weight by 21% in obese people
Researchers at Hospital Clínic-IDIBAPS describe a new efficacious treatment in giant cell arteritis
The administration of the antibody mavrilimumab in conjunction with prednisone reduces the risk of exacerbation of symptoms of the disease and improv1
Polygenic risk scores for cognitive functioning are linked to clinical progression following first-episode psychosis
Researchers from the Hospital Clínic-IDIBAPS and the CIBERSAM participate in a study that evidences the involvement of numerous genes in the developm1
Insomnia drug approved in Europe
Studies have shown that this drug improves sleep and daytime performance in people with insomnia, without causing a sedative effect the next day, as1
The Hospital CLÍNIC-IDIBAPS is leading a study to identify people who may develop Parkinson’s disease
Researchers from the Hospital Clínic-IDIBAPS are leading a study to obtain information on 10,000 healthy people who do not have Parkinson's disease,1